Study of substances in blood suggests choroideremia is not just an isolated eye disease
Choroideremia is a rare genetic condition resulting in progressive sight loss in men.
Search results
Choroideremia is a rare genetic condition resulting in progressive sight loss in men.
Retina UK is delighted that the Scottish Medicines Consortium (SMC) has accepted the gene therapy Luxturna (voretigene neparvovec) for ongoing use by the NHS in Scotland.
Tuesday 22 October, 7.00pm - 8.00pm - Via Zoom - Come and join us for an online Autumn social catch up.
Please read our conditions of use carefully as by using the website you will be assumed to have agreed to be bound by them.
Retina UK is delighted to announce that it has awarded three new research grants worth more than Β£870,000.
When we talk about gene therapy we are usually referring to use of a harmless virus, called a vector, to deliver a normal copy of a defective gene into the cells of the eye.
Our Peer Support Groups are growing. Find out more about what's planned for the future.
Saturday 9 November, 9.45am - 4pm - In-person - Join us for an exclusive tour and handling session at the National Trust Back to Backs in Birmingham followed by lunch at The Sly Old Fox.
Despite the challenges of the pandemic, researchers and pharmaceutical companies are still making progress towards delivering new treatments for inherited sight loss.
Join Research Development Manager, Kate Arkell as she speaks to our latest research grantees about their projects.